Autor: |
Tanriover, Mine Durusu, Doğanay, Hamdi Levent, Akova, Murat, Güner, Hatice Rahmet, Azap, Alpay, Akhan, Sıla, Köse, Şükran, Erdinç, Fatma Şebnem, Akalın, Emin Halis, Tabak, Ömer Fehmi, Pullukçu, Hüsnü, Batum, Özgür, Şimşek Yavuz, Serap, Turhan, Özge, Yıldırmak, Mustafa Taner, Köksal, İftihar, Taşova, Yeşim, Korten, Volkan, Yılmaz, Gürdal, Çelen, Mustafa Kemal, Altın, Sedat, Çelik, İlhami, Bayındır, Yaşar, Karaoğlan, İlkay, Yılmaz, Aydın, Özkul, Aykut, Gür, Hazal, Unal, Serhat, Kayaaslan, Bircan, Hasanoğlu, İmran, Dalkıran, Ayça, Aydos, Ömer, Çınar, Güle, Akdemir-Kalkan, İrem, İnkaya, Ahmet Çağkan, Aydin, Mehtap, Çakir, Hatice, Yıldız, Jale, Kocabıyık, Özenir, Arslan, Sonay, Nallı, Bayram, Demir, Ömer, Singil, Sarp, Ataman-Hatipoğlu, Çiğdem, Tuncer-Ertem, Günay, Kınıklı, Sami, Önal, Uğur, Mete, Bilgül, Dalgan, Gözde, Taşbakan, Meltem, Yamazhan, Tansu, Kömürcüoğlu, Berna, Yalnız, Enver, Benli, Aysun, Keskin-Sarıtaş, Çağla, Ertosun, Mustafa Gökhan, Özkan, Özlenen, Emre, Salih, Arıca, Seçil, Kuşçu, Ferit, Candevir, Aslıhan, Ertürk-Şengel, Buket, Ayvaz, Fadime, Aksoy, Firdevs, Mermutluoğlu, Çiğdem, Demir, Yakup, Günlüoğlu, Gülşah, Tural-Önür, Seda, Kılıç-Toker, Ayşin, Eren, Esma, Otlu, Barış, Mete, Ayşe Özlem, Koçak, Kübra, Ateş, Hale, Koca-Kalkan, İlkay, Aksu, Kurtuluş |
Zdroj: |
The Lancet; July 2021, Vol. 398 Issue: 10296 p213-222, 10p |
Abstrakt: |
CoronaVac, an inactivated whole-virion SARS-CoV-2 vaccine, has been shown to be well tolerated with a good safety profile in individuals aged 18 years and older in phase 1/2 trials, and provided a good humoral response against SARS-CoV-2. We present the interim efficacy and safety results of a phase 3 clinical trial of CoronaVac in Turkey. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|